Moreover, in the mouse model of chronic liver injury caused by tyrosinemia or long-term treatments of CCl4, IGF2 can significantly promote hepatocyte proliferation and tissue repair in the condition of chronic liver injury (Liu et al. 2017). Here, IGF2 is linked to tyrosinemia.